AstraZeneca PLC (NASDAQ:AZN) is a cheap growth stock with promising earnings growth projections and a robust pipeline. Analysts recommend buying, expecting a 21% upside. Despite its potential, other AI stocks are favored for higher returns in a shorter timeframe.